Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem + lidocaine gel versus Proctyl for chronic anal fissure
RBR-3bhzqsmPhase 3Not yet recruiting
- Sponsor
- Santa Casa de Santos
- Start
- Dec 2024
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of diltiazem, lidocaine, policresulen and cinchocaine in chronic anal fissure (CAF) (2 arms), sponsored by Santa Casa de Santos. Primary endpoint: Primary endpoint not specified. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
diltiazemlidocainepolicresulencinchocaine
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on RBR-3bhzqsm.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3bhzqsm.